Zhengwen Ning

Statistics

Publications

Citations

473

H-Index

Active since

1995

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Shenzhen Chipscreen Biosciences Co.

Zhengwen Ning is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and pharmacology.

Publications per year

1995–2015

Publications

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Yue Shi, Mei Dong, Xiaoting Hong et al. · Annals of Oncology · 2015 · 396 citations

Medicine, Immunology, Oncology +11

<i>In Vitro</i>and<i>In Vivo</i>Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

Bing He, Zhengwen Ning, Zeqian Li et al. · PPAR Research · 2012 · 51 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Phase I study of chidamide (CS055/HBI-8000), a novel histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

Mei Dong, Zhengwen Ning, Michael Newman et al. · Journal of Clinical Oncology · 2009 · 15 citations

Medicine, Oncology, Pharmacology +14

Early Gene Signaling-Dependent and -Independent Induction of Apoptosis in Ramos Human B Cells Can Be Inhibited by over-Expression of BCL-2

Zhengwen Ning, John D. Norton, D.H. Johnson et al. · Biochemical and Biophysical Research Communications · 1995 · 11 citations

Life Sciences, Cell Biology, Molecular Biology +15

1–4 of 4